[A16-29] Sacubitril/valsartan - Addendum to Commission A15-60
Last updated 16.06.2016
Project no.:
A16-29
Commission:
Commission awarded on 09.05.2016 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
| Project no. | Title | Status |
|---|---|---|
| A15-60 | Sacubitril/valsartan - Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2016-06-16 A G-BA decision was published.